HHS warns of severe risks from sex-change procedures for minors
- A new report by the U.S. Department of Health and Human Services raises concerns about medical interventions for minors with gender dysphoria.
- Interventions like puberty blockers and surgeries are said to carry significant health risks with little evidence of benefit.
- The report has sparked debate about the ethics of gender transition treatments and the need for evidence-based medical practices.
On April 30, 2025, the U.S. Department of Health and Human Services (HHS) published a comprehensive review regarding medical interventions for minors experiencing gender dysphoria. The report outlines the significant risks associated with practices such as puberty blockers, hormone therapies, and sex-change surgeries. These medical procedures have been linked to severe, irreversible effects, including infertility, sexual dysfunction, and psychiatric disorders. The HHS report asserts that there is very weak evidence supporting the benefits of these interventions, which raises ethical concerns regarding their application to children and teens. This initiative appears to align with President Donald Trump's executive order aimed at protecting children from what he describes as